Vandevenne, Patricia ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Virologie et immunologie
Sadzot-Delvaux, Catherine ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Virologie et immunologie - GIGA-M : Coordination scientifique
Piette, Jacques ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Virologie - Immunologie - Département des sciences de la vie - GIGA-Research
Language :
English
Title :
Innate immune response and viral interference strategies developed by Human Herpeviruses
Koyama S., Ishii K.J., Coban C., Akira S. Innate immune response to viral infection. Cytokine 2008, 43(3):336-341.
Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27(3):370-383.
Takeuchi O., Akira S. Innate immunity to virus infection. Immunol Rev 2009, 227(1):75-86.
Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388(4):621-625.
Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448(7152):501-505.
Takaoka A., Taniguchi T. Cytosolic DNA recognition for triggering innate immune responses. Adv Drug Deliv Rev 2008, 60(7):847-857.
Burckstummer T., Baumann C., Bluml S., Dixit E., Durnberger G., Jahn H., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009, 10(3):266-272.
Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458(7237):514-518.
Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452(7183):103-107.
Stutz Andrea D.T.G., Eicke L. Inflammasomes: too big to miss. J Clin Invest 2009, 119(12):3501-3511.
Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002, 14(4):432-436.
Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
Boehme K.W., Compton T. Innate sensing of viruses by toll-like receptors. J Virol 2004, 78(15):7867-7873.
Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801.
Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140(6):805-820.
Hallman M., Ramet M., Ezekowitz R.A. Toll-like receptors as sensors of pathogens. Pediatr Res 2001, 50(3):315-321.
McKenna K., Beignon A.S., Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 2005, 79(1):17-27.
Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2(8):675-680.
Krieg A.M., Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007, 220:251-269.
Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11(5):373-384.
Kawai T., Akira S. TLR signaling. Semin Immunol 2007, 19(1):24-32.
Tsan M.F. Toll-like receptors, inflammation and cancer. Semin Cancer Biol 2006, 16(1):32-37.
Gohda J., Matsumura T., Inoue J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J Immunol 2004, 173(5):2913-2917.
Landstrom M. The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 2010, 42(5):585-589.
Keating S.E., Maloney G.M., Moran E.M., Bowie A.G. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem 2007, 282(46):33435-33443.
Lin S.-C., Lo Y.-C., Wu H. Helicase assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010, 465:885-890.
Sheedy F.J., O'Neill L.A. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J Leukoc Biol 2007, 82(2):196-203.
Chen N.J., Chio I.I., Lin W.J., Duncan G., Chau H., Katz D., et al. Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci U S A 2008, 105(34):12429-12434.
Jiang Z., Zamanian-Daryoush M., Nie H., Silva A.M., Williams B.R., Li X. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem 2003, 278(19):16713-16719.
Jiang Z., Mak T.W., Sen G., Li X. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci U S A 2004, 101(10):3533-3538.
Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003, 4(5):491-496.
Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2005, 439:208-211.
Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 2004, 101(5):1315-1320.
Wang J.P., Kurt-Jones E.A., Shin O.S., Manchak M.D., Levin M.J., Finberg R.W. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 2005, 79(20):12658-12666.
Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77(8):4588-4596.
Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006, 80(10):5059-5064.
Edelmann K.H., Richardson-Burns S., Alexopoulou L., Tyler K.L., Flavell R.A., Oldstone M.B. Does Toll-like receptor 3 play a biological role in virus infections?. Virology 2004, 322(2):231-238.
Zhang S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317(5844):1522-1527.
Iwakiri D., Zhou L., Samanta M., Matsumoto M., Ebihara T., Seya T., et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009, 206(10):2091-2099.
Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198(3):513-520.
Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103(4):1433-1437.
Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5(7):730-737.
Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005, 175(5):2851-2858.
Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 2005, 175(8):5260-5268.
Satoh T.K.H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., Tsujimura T., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2009, 107(4):1512-1517.
Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122(5):669-682.
Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437(7062):1167-1172.
Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005, 19(6):727-740.
Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6(10):981-988.
Michallet M.C., Meylan E., Ermolaeva M.A., Vazquez J., Rebsamen M., Curran J., et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 2008, 28(5):651-661.
Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455(7213):674-678.
Sun W., Li Y., Chen L., Chen H., You F., Zhou X., et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci U S A 2009, 106(21):8653-8658.
Jin L., Waterman P.M., Jonscher K.R., Short C.M., Reisdorph N.A., Cambier J.C. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol Cell Biol 2008, 28(16):5014-5026.
Zhong B., Yang Y., Li S., Wang Y.Y., Li Y., Diao F., et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008, 29(4):538-550.
Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461(7265):788-792.
Soulat D., Burckstummer T., Westermayer S., Goncalves A., Bauch A., Stefanovic A., et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. Embo J 2008, 27(15):2135-2146.
Schroder M., Baran M., Bowie A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. Embo J 2008, 27(15):2147-2157.
Oshiumi H., Sakai K., Matsumoto M., Seya T. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur J Immunol 2010, 40(4):940-948.
Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441(7089):101-105.
Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., et al. 5'-Triphosphate RNA Is the Ligand for RIG-I. Science 2006, 314:935-936.
Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5' phosphates. Science 2006, 314:997-1001.
Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31(1):25-34.
Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., Wenzel M., et al. 5'-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106(29):12067-12072.
Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140(3):397-408.
Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006, 103(22):8459-8464.
Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205(7):1601-1610.
Rasmussen S.B., Sorensen L.N., Malmgaard L., Ank N., Baines J.D., Chen Z.J., et al. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol 2007, 81(24):13315-13324.
Rasmussen S.B., Jensen S.B., Nielsen C., Quartin E., Kato H., Chen Z.J., et al. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J Gen Virol 2009, 90(Pt 1):74-78.
Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138(3):576-591.
Samanta M., Iwakiri D., Kanda T., Imaizumi T., Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. Embo J 2006, 25(18):4207-4214.
Pedra J.H., Cassel S.L., Sutterwala F.S. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 2009, 21(1):10-16.
Stutz A., Golenbock D.T., Latz E. Inflammasomes: too big to miss. J Clin Invest 2009, 119(12):3502-3511.
Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140(6):821-832.
Finlay HBYBB The caspase-1 inflammasome: a pilot of innate immune response. Cell Host Microbe 2008, 4:198-208.
Franchi L., Warner N., Viani K., Nunez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009, 227(1):106-128.
Brodsky I.E., Monack D. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol 2009, 21(4):199-207.
Owen D.M., Gale M. Fighting the flu with inflammasome signaling. Immunity 2009, 30(4):476-478.
Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30(4):556-565.
Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30(4):566-575.
Delaloye J.R.T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. Plos Pathogen 2009, 5(6).
Sabbah A., Chang T.H., Harnack R., Frohlich V., Tominaga K., Dube P.H., et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009, 10(10):1073-1080.
Murray P.J. Beyond peptidoglycan for Nod2. Nat Immunol 2009, 10(10):1053-1054.
Rathinam V.A.K., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010, 11(5):395-403.
Fernandes-Alnemri T., Yu J.-W., Juliana C., Solorzano L., Kang S., Wu J., et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010, 11(5):38-94.
Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006, 7(1):40-48.
Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A 2008, 105(14):5477-5482.
DeFilippis V.R., Alvarado D., Sali T., Rothenburg S., Fruh K. Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol 2010, 84(1):585-598.
Bonjardim C.A., Ferreira P.C., Kroon E.G. Interferons: signaling, antiviral and viral evasion. Immunol Lett 2009, 122(1):1-11.
Randall R.E., Goodbourn S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89(Pt 1):1-47.
Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14(4):778-809.
Preston C.M., Harman A.N., Nicholl M.J. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 2001, 75(19):8909-8916.
Collins S.E., Noyce R.S., Mossman K.L. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004, 78(4):1706-1717.
Mossman K.L., Macgregor P.F., Rozmus J.J., Goryachev A.B., Edwards A.M., Smiley J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001, 75(2):750-758.
Nicholl M.J., Robinson L.H., Preston C.M. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 2000, 81(Pt 9):2215-2218.
Paladino P., Mossman K.L. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res 2009, 29(9):599-607.
Pasieka T.J., Baas T., Carter V.S., Proll S.C., Katze M.G., Leib D.A. Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response. J Virol 2006, 80(15):7600-7612.
He B., Gross M., Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 1997, 94(3):843-848.
Verpooten D., Ma Y., Hou S., Yan Z., He B. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem 2009, 284(2):1097-1105.
Eidson K.M., Hobbs W.E., Manning B.J., Carlson P., DeLuca N.A. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol 2002, 76(5):2180-2191.
Lin R., Noyce R.S., Collins S.E., Everett R.D., Mossman K.L. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004, 78(4):1675-1684.
Melroe G.T., Silva L., Schaffer P.A., Knipe D.M. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology 2007, 360(2):305-321.
Paladino P., Collins S.E., Mossman K.L. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One 2010, 5(4):e10428.
Melchjorsen J., Siren J., Julkunen I., Paludan S.R., Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J Gen Virol 2006, 87(Pt 5):1099-1108.
Johnson K.E., Song B., Knipe D.M. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 2008, 374(2):487-494.
Johnson K.E., Knipe D.M. Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation. Virology 2010, 396(1):21-29.
Cassady K.A., Gross M., Roizman B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J Virol 1998, 72(11):8620-8626.
Sanchez R., Mohr I. Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein. J Virol 2007, 81(7):3455-3464.
Matis J., Kudelova M. Early shutoff of host protein synthesis in cells infected with herpes simplex viruses. Acta Virol 2001, 45(5-6):269-277.
Kwong A.D., Frenkel N. The herpes simplex virus virion host shutoff function. J Virol 1989, 63(11):4834-4839.
Abendroth A., Slobedman B., Lee E., Mellins E., Wallace M., Arvin A.M. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J Virol 2000, 74(4):1900-1907.
Abendroth A., Lin I., Slobedman B., Ploegh H., Arvin A.M. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001, 75(10):4878-4888.
Jones J.O., Arvin A.M. Inhibition of the NF-{kappa}B pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 2006, 80(11):5113-5124.
El Mjiyad N., Bontems S., Gloire G., Horion J., Vandevenne P., Dejardin E., et al. Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters. J Virol 2007, 81(23):13092-13104.
Huch J.H., Cunningham A.L., Arvin A.M., Nasr N., Santegoets S.J., Slobedman E., et al. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J Virol 2010, 84(8):4060-4072.
Boehme K.W., Singh J., Perry S.T., Compton T. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol 2004, 78(3):1202-1211.
DeFilippis V.R., Robinson B., Keck T.M., Hansen S.G., Nelson J.A., Fruh K.J. Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection. J Virol 2006, 80(2):1032-1037.
Abate D.A., Watanabe S., Mocarski E.S. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 2004, 78(20):10995-11006.
Taylor R.T., Bresnahan W.A. Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 2006, 80(2):920-928.
Taylor R.T., Bresnahan W.A. Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J Virol 2005, 79(6):3873-3877.
Taylor R.T., Bresnahan W.A. Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression. J Virol 2006, 80(21):10763-10771.
Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman J.W., et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998, 187(5):675-683.
Miller D.M., Zhang Y., Rahill B.M., Waldman W.J., Sedmak D.D. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 1999, 162(10):6107-6113.
Hahn A.M., Huye L.E., Ning S., Webster-Cyriaque J., Pagano J.S. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J Virol 2005, 79(15):10040-10052.
Wang J.T., Doong S.L., Teng S.C., Lee C.P., Tsai C.H., Chen M.R. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J Virol 2009, 83(4):1856-1869.
Wu L., Fossum E., Joo C.H., Inn K.S., Shin Y.C., Johannsen E., et al. Epstein-Barr virus LF2: an antagonist to type I interferon. J Virol 2009, 83(2):1140-1146.
Shah K.M., Stewart S.E., Wei W., Woodman C.B., O'Neil J.D., Dawson C.W., et al. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene 2009, 28(44):3903-3914.
Bentz G.L., Liu R., Hahn A.M., Shackelford J., Pagano J.S. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology 2010, 402(1):121-128.
